tremelimumab
Consolidation Immunotherapy in Limited-Stage Small Cell Lung Cancer Improves Overall Survival
After platinum-based chemoradiotherapy, a consolidation immunotherapy regimen significantly improved overall ...
JUNE 12, 2024
Novel First-Line Therapy’s OS Benefit for Liver Cancer Persists
Long-term overall survival in hepatocellular carcinoma with tremelimumab plus durvalumab treatment is durable, ...
NOVEMBER 27, 2023
Tremelimumab/Durvalumab Combo Promising for Unresectable HCC
Combining a single priming dose of tremelimumab and durvalumab significantly improved overall survival in the ...
FEBRUARY 10, 2022
Load more